table of content
1 Study Coverage
1.1 Pulmonary Drug Delivery Devices/Systems Product Introduction
1.2 Global Pulmonary Drug Delivery Devices/Systems Outlook 2017 VS 2022 VS 2028
1.2.1 Global Pulmonary Drug Delivery Devices/Systems Sales in US$ Million for the Year 2017-2028
1.2.2 Global Pulmonary Drug Delivery Devices/Systems Sales in Volume for the Year 2017-2028
1.3 United States Pulmonary Drug Delivery Devices/Systems Outlook 2017 VS 2022 VS 2028
1.3.1 United States Pulmonary Drug Delivery Devices/Systems Sales in US$ Million for the Year 2017-2028
1.3.2 United States Pulmonary Drug Delivery Devices/Systems Sales in Volume for the Year 2017-2028
1.4 Pulmonary Drug Delivery Devices/Systems Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Pulmonary Drug Delivery Devices/Systems in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Pulmonary Drug Delivery Devices/Systems Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Pulmonary Drug Delivery Devices/Systems Market Dynamics
1.5.1 Pulmonary Drug Delivery Devices/Systems Industry Trends
1.5.2 Pulmonary Drug Delivery Devices/Systems Market Drivers
1.5.3 Pulmonary Drug Delivery Devices/Systems Market Challenges
1.5.4 Pulmonary Drug Delivery Devices/Systems Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Pulmonary Drug Delivery Devices/Systems Market Segment by Type
2.1.1 Metered Dose Inhalers
2.1.2 Dry Powder Inhalers
2.1.3 Nebulizers
2.1.4 Accessories
2.2 Global Pulmonary Drug Delivery Devices/Systems Market Size by Type
2.2.1 Global Pulmonary Drug Delivery Devices/Systems Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Pulmonary Drug Delivery Devices/Systems Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Pulmonary Drug Delivery Devices/Systems Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Pulmonary Drug Delivery Devices/Systems Market Size by Type
2.3.1 United States Pulmonary Drug Delivery Devices/Systems Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Pulmonary Drug Delivery Devices/Systems Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Pulmonary Drug Delivery Devices/Systems Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Pulmonary Drug Delivery Devices/Systems Market Segment by Application
3.1.1 Hospitals and Clinics
3.1.2 Homecare
3.2 Global Pulmonary Drug Delivery Devices/Systems Market Size by Application
3.2.1 Global Pulmonary Drug Delivery Devices/Systems Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Pulmonary Drug Delivery Devices/Systems Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Pulmonary Drug Delivery Devices/Systems Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Pulmonary Drug Delivery Devices/Systems Market Size by Application
3.3.1 United States Pulmonary Drug Delivery Devices/Systems Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Pulmonary Drug Delivery Devices/Systems Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Pulmonary Drug Delivery Devices/Systems Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Pulmonary Drug Delivery Devices/Systems Competitor Landscape by Company
4.1 Global Pulmonary Drug Delivery Devices/Systems Market Size by Company
4.1.1 Top Global Pulmonary Drug Delivery Devices/Systems Manufacturers Ranked by Revenue (2021)
4.1.2 Global Pulmonary Drug Delivery Devices/Systems Revenue by Manufacturer (2017-2022)
4.1.3 Global Pulmonary Drug Delivery Devices/Systems Sales by Manufacturer (2017-2022)
4.1.4 Global Pulmonary Drug Delivery Devices/Systems Price by Manufacturer (2017-2022)
4.2 Global Pulmonary Drug Delivery Devices/Systems Concentration Ratio (CR)
4.2.1 Pulmonary Drug Delivery Devices/Systems Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pulmonary Drug Delivery Devices/Systems in 2021
4.2.3 Global Pulmonary Drug Delivery Devices/Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Pulmonary Drug Delivery Devices/Systems Manufacturing Base Distribution, Product Type
4.3.1 Global Pulmonary Drug Delivery Devices/Systems Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Pulmonary Drug Delivery Devices/Systems Product Type
4.3.3 Date of International Manufacturers Enter into Pulmonary Drug Delivery Devices/Systems Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Pulmonary Drug Delivery Devices/Systems Market Size by Company
4.5.1 Top Pulmonary Drug Delivery Devices/Systems Players in United States, Ranked by Revenue (2021)
4.5.2 United States Pulmonary Drug Delivery Devices/Systems Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Pulmonary Drug Delivery Devices/Systems Sales by Players (2020, 2021 & 2022)
5 Global Pulmonary Drug Delivery Devices/Systems Market Size by Region
5.1 Global Pulmonary Drug Delivery Devices/Systems Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Pulmonary Drug Delivery Devices/Systems Market Size in Volume by Region (2017-2028)
5.2.1 Global Pulmonary Drug Delivery Devices/Systems Sales in Volume by Region: 2017-2022
5.2.2 Global Pulmonary Drug Delivery Devices/Systems Sales in Volume Forecast by Region (2023-2028)
5.3 Global Pulmonary Drug Delivery Devices/Systems Market Size in Value by Region (2017-2028)
5.3.1 Global Pulmonary Drug Delivery Devices/Systems Sales in Value by Region: 2017-2022
5.3.2 Global Pulmonary Drug Delivery Devices/Systems Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Pulmonary Drug Delivery Devices/Systems Market Size YoY Growth 2017-2028
6.1.2 North America Pulmonary Drug Delivery Devices/Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Pulmonary Drug Delivery Devices/Systems Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Pulmonary Drug Delivery Devices/Systems Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Pulmonary Drug Delivery Devices/Systems Market Size YoY Growth 2017-2028
6.3.2 Europe Pulmonary Drug Delivery Devices/Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Pulmonary Drug Delivery Devices/Systems Market Size YoY Growth 2017-2028
6.4.2 Latin America Pulmonary Drug Delivery Devices/Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Hovione
7.1.1 Hovione Corporation Information
7.1.2 Hovione Description and Business Overview
7.1.3 Hovione Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Hovione Pulmonary Drug Delivery Devices/Systems Products Offered
7.1.5 Hovione Recent Development
7.2 3M Health Care
7.2.1 3M Health Care Corporation Information
7.2.2 3M Health Care Description and Business Overview
7.2.3 3M Health Care Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2017-2022)
7.2.4 3M Health Care Pulmonary Drug Delivery Devices/Systems Products Offered
7.2.5 3M Health Care Recent Development
7.3 Bespak
7.3.1 Bespak Corporation Information
7.3.2 Bespak Description and Business Overview
7.3.3 Bespak Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Bespak Pulmonary Drug Delivery Devices/Systems Products Offered
7.3.5 Bespak Recent Development
7.4 BeyonDevices
7.4.1 BeyonDevices Corporation Information
7.4.2 BeyonDevices Description and Business Overview
7.4.3 BeyonDevices Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2017-2022)
7.4.4 BeyonDevices Pulmonary Drug Delivery Devices/Systems Products Offered
7.4.5 BeyonDevices Recent Development
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporation Information
7.5.2 GlaxoSmithKline Description and Business Overview
7.5.3 GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2017-2022)
7.5.4 GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Products Offered
7.5.5 GlaxoSmithKline Recent Development
7.6 H&T Presspart
7.6.1 H&T Presspart Corporation Information
7.6.2 H&T Presspart Description and Business Overview
7.6.3 H&T Presspart Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2017-2022)
7.6.4 H&T Presspart Pulmonary Drug Delivery Devices/Systems Products Offered
7.6.5 H&T Presspart Recent Development
7.7 PARI Respiratory Equipment
7.7.1 PARI Respiratory Equipment Corporation Information
7.7.2 PARI Respiratory Equipment Description and Business Overview
7.7.3 PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2017-2022)
7.7.4 PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Products Offered
7.7.5 PARI Respiratory Equipment Recent Development
7.8 Philips Respironics
7.8.1 Philips Respironics Corporation Information
7.8.2 Philips Respironics Description and Business Overview
7.8.3 Philips Respironics Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Philips Respironics Pulmonary Drug Delivery Devices/Systems Products Offered
7.8.5 Philips Respironics Recent Development
7.9 SHL
7.9.1 SHL Corporation Information
7.9.2 SHL Description and Business Overview
7.9.3 SHL Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2017-2022)
7.9.4 SHL Pulmonary Drug Delivery Devices/Systems Products Offered
7.9.5 SHL Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Pulmonary Drug Delivery Devices/Systems Industry Chain Analysis
8.2 Pulmonary Drug Delivery Devices/Systems Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Pulmonary Drug Delivery Devices/Systems Distributors
8.3 Pulmonary Drug Delivery Devices/Systems Production Mode & Process
8.4 Pulmonary Drug Delivery Devices/Systems Sales and Marketing
8.4.1 Pulmonary Drug Delivery Devices/Systems Sales Channels
8.4.2 Pulmonary Drug Delivery Devices/Systems Distributors
8.5 Pulmonary Drug Delivery Devices/Systems Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
